KCTD3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.657400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.000200E-01
Normal-vs-Stage2
4.708600E-01
Normal-vs-Stage3
9.711800E-01
Normal-vs-Stage4
4.763200E-01
Stage1-vs-Stage2
1.887560E-01
Stage1-vs-Stage3
2.337600E-01
Stage1-vs-Stage4
5.270000E-01
Stage2-vs-Stage3
4.411400E-01
Stage2-vs-Stage4
8.175200E-01
Stage3-vs-Stage4
4.063400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.977400E-01
Normal-vs-AfricanAmerican
3.112000E-01
Normal-vs-Asian
5.112200E-01
Caucasian-vs-AfricanAmerican
5.758600E-01
Caucasian-vs-Asian
4.792800E-01
AfricanAmerican-vs-Asian
9.965600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.679600E-01
Normal-vs-Female
4.728800E-01
Male-vs-Female
5.943000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.713200E-01
Normal-vs-Age(41-60Yrs)
3.601200E-01
Normal-vs-Age(61-80Yrs)
5.176000E-01
Normal-vs-Age(81-100Yrs)
4.848000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.778600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.452600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.815200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.953000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.000600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.638600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.036400E-01
Normal-vs-Daily Drinker
9.100800E-01
Normal-vs-Weekly Drinker
6.778600E-01
Normal-vs-Occasional Drinker
4.384200E-01
Normal-vs-Social Drinker
3.288800E-01
Non Drinker-vs-Daily Drinker
4.086100E-02
Non Drinker-vs-Weekly Drinker
7.623600E-01
Non Drinker-vs-Occasional Drinker
9.290000E-01
Non Drinker-vs-Social Drinker
5.432400E-01
Daily Drinker-vs-Weekly Drinker
2.658800E-01
Daily Drinker-vs-Occasional Drinker
7.942200E-02
Daily Drinker-vs-Social Drinker
3.094500E-02
Weekly Drinker-vs-Occasional Drinker
8.370200E-01
Weekly Drinker-vs-Social Drinker
5.233800E-01
Occasional Drinker-vs-Social Drinker
5.301800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.230200E-02
Normal-vs-Grade 2
5.478100E-03
Normal-vs-Grade 3
1.040240E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.135200E-01
Grade 1-vs-Grade 3
2.399800E-01
Grade 1-vs-Grade 4
5.230200E-02
Grade 2-vs-Grade 3
1.994410E-01
Grade 2-vs-Grade 4
5.478100E-03
Grade 3-vs-Grade 4
1.040240E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.900000E-01
Normal-vs-NonDiabetic
4.061000E-01
Diabetic-vs-NonDiabetic
5.456500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.066800E-01
Normal-vs-NoPancreatitis
5.334600E-01
Pancreatitis-vs-NoPancreatitis
2.086400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.165600E-01
Normal-vs-N1
4.906000E-01
N0-vs-N1
5.294200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.762040E-01
Normal-vs-TP53-NonMutant
3.550800E-01
TP53-Mutant-vs-TP53-NonMutant
3.582600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
